U6Z
1-[(~{E})-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
Created: | 2021-01-25 |
Last modified: | 2021-07-21 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 23 |
Chiral Atom Count | 0 |
Bond Count | 24 |
Aromatic Bond Count | 5 |
Chemical Component Summary | |
---|---|
Name | 1-[(~{E})-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione |
Synonyms | Nitrofurantoin |
Systematic Name (OpenEye OEToolkits) | 1-[(~{E})-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione |
Formula | C8 H6 N4 O5 |
Molecular Weight | 238.157 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | CACTVS | 3.385 | O=C1CN(N=Cc2oc(cc2)[N](=O)=O)C(=O)N1 |
SMILES | OpenEye OEToolkits | 2.0.7 | c1cc(oc1C=NN2CC(=O)NC2=O)N(=O)=O |
Canonical SMILES | CACTVS | 3.385 | O=C1CN(/N=C/c2oc(cc2)[N](=O)=O)C(=O)N1 |
Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1cc(oc1/C=N/N2CC(=O)NC2=O)N(=O)=O |
InChI | InChI | 1.03 | InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+ |
InChIKey | InChI | 1.03 | NXFQHRVNIOXGAQ-YCRREMRBSA-N |
Drug Info: DrugBank
DrugBank ID | DB00698 |
---|---|
Name | Nitrofurantoin |
Groups |
|
Description | Nitrofurantoin is a nitrofuran antibiotic used to treat uncomplicated urinary tract infections.[L6856,L6859,L6862] Nitrofurantoin is converted by bacterial nitroreductases to electrophilic intermediates which inhibit the citric acid cycle as well as synthesis of DNA, RNA, and protein.[A179824] This drug is more resistant to the development of bacterial resistance because it acts on many targets at once.[A179824] Nitrofurantoin is a second line treatment to [trimethoprim]/[sulfamethoxazole].[A179830] Nitrofurantoin was granted FDA approval on 6 February 1953.[L6895] |
Synonyms |
|
Brand Names |
|
Indication | Nitrofurantoin is indicated to treat acute uncomplicated urinary tract infections.[L6856,L6859,L6862] |
Categories |
|
ATC-Code |
|
CAS number | 67-20-9 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Probable pyruvate-flavodoxin oxidoreductase | MITIDGNGAVASVAFRTSEVIAIYPITPSSTMAEQADAWAGNGLKNVWGD... | unknown | potentiator |
Oxygen-insensitive NADPH nitroreductase | MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIR... | unknown | potentiator |
30S ribosomal protein S10 | MQNQRIRIRLKAFDHRLIDQATAEIVETAKRTGAQVRGPIPLPTRKERFT... | unknown | inhibitor |
NADPH--cytochrome P450 reductase | MGDSHVDTSSTVSEAVAEEVSLFSMTDMILFSLIVGLLTYWFLFRKKKEE... | unknown | substrate |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL572 |
PubChem | 6604200 |
ChEMBL | CHEMBL572 |
ChEBI | CHEBI:71415, CHEBI:95222 |